Research article
319 views
Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential.
ACS infectious diseases, 2020
Abstract
The recent outbreak of coronavirus disease 2019 (COVID-19) highlights an urgent need for therapeutics. Through a series of drug repurposing screening campaigns, niclosamide, an FDA-approved anthelminthic drug, was found to be effective against various viral infections with nanomolar to micromolar potency such as SARS-CoV, MERS-CoV, ZIKV, HCV, and human adenovirus, indicating its potential as an antiviral agent. In this brief review, we summarize the broad antiviral activity of niclosamide and highlight its potential clinical use in the treatment of COVID-19.
Keywords
How to cite
Xu, Jimin; Shi, Pei-Yong; Li, Hongmin; Zhou, Jia. (2020). Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential. ACS infectious diseases. https://doi.org/10.1021/acsinfecdis.0c00052
Ref key
xu2020broadacs
Type this key in a SciMatic manuscript or in Thesis Manager to cite this paper automatically.
References
No references are recorded for this paper yet.
